Vifor (International) Ltd - 15 Apr 2025 SCHEDULE 13D/A Report for Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) Common Stock, par value $0.001 per share

Filing Manager: Vifor (International) Ltd
Reporting Manager: Vifor (International) Ltd.
Security: Tvardi Therapeutics, Inc. (formerly, Cara Therapeutics, Inc.) Common Stock, par value $0.001 per share
Shares outstanding: 9.34M shares
Disclosed Ownership: 205K shares
Ownership: 2.2%
Form type: SCHEDULE 13D/A
Filing time: 16 Apr 2025, 16:15:10 UTC
Date of event: 15 Apr 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Vifor (International) Ltd.	2.2%	205K	0	205K	/s/ Alexandros Sigalas	Alexandros Sigalas, Head of Finance, CSL Vifor	0001675217
CSL Limited	2.2%	205K	0	205K	/s/ Fiona Mead	Fiona Mead, Company Secretary